Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Visar Belegu is active.

Publication


Featured researches published by Visar Belegu.


Experimental Neurology | 2013

Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPσ

James Pendleton; Michael J. Shamblott; Devin S. Gary; Visar Belegu; Andres Hurtado; Misti Malone; John W. McDonald

CNS damage often results in demyelination of spared axons due to oligodendroglial cell death and dysfunction near the injury site. Although new oligodendroglia are generated following CNS injury and disease, the process of remyelination is typically incomplete resulting in long-term functional deficits. Chondroitin sulfate proteoglycans (CSPGs) are upregulated in CNS grey and white matter following injury and disease and are a major component of the inhibitory scar that suppresses axon regeneration. CSPG inhibition of axonal regeneration is mediated, at least in part, by the protein tyrosine phosphatase sigma (PTPσ) receptor. Recent evidence demonstrates that CSPGs inhibit OL process outgrowth, however, the means by which their effects are mediated remains unclear. Here we investigate the role of PTPσ in CSPG inhibition of OL function. We found that the CSPGs, aggrecan, neurocan and NG2 all imposed an inhibitory effect on OL process outgrowth and myelination. These inhibitory effects were reversed by degradation of CSPGs with Chondroitinase ABC prior to OL exposure. RNAi-mediated down-regulation of PTPσ reversed the inhibitory effect of CSPGs on OL process outgrowth and myelination. Likewise, CSPG inhibition of process outgrowth and myelination was significantly reduced in cultures containing PTPσ(-/-) OLs. Finally, inhibition of Rho-associated kinase (ROCK) increased OL process outgrowth and myelination during exposure to CSPGs. These results suggest that in addition to their inhibitory effects on axon regeneration, CSPGs have multiple inhibitory actions on OLs that result in incomplete remyelination following CNS injury. The identification of PTPσ as a receptor for CSPGs, and the participation of ROCK downstream of CSPG exposure, reveal potential therapeutic targets to enhance white matter repair in the damaged CNS.


NMR in Biomedicine | 2009

Reproducibility of tract-specific magnetization transfer and diffusion tensor imaging in the cervical spinal cord at 3 tesla.

Seth A. Smith; Craig K. Jones; Aliya Gifford; Visar Belegu; BettyAnn Chodkowski; Jonathan A.D. Farrell; Bennett A. Landman; Daniel S. Reich; Peter A. Calabresi; John W. McDonald; Peter C.M. van Zijl

Damage to specific white matter tracts within the spinal cord can often result in the particular neurological syndromes that characterize myelopathies such as traumatic spinal cord injury. Noninvasive visualization of these tracts with imaging techniques that are sensitive to microstructural integrity is an important clinical goal. Diffusion tensor imaging (DTI)‐ and magnetization transfer (MT)‐derived quantities have shown promise in assessing tissue health in the central nervous system. In this paper, we demonstrate that DTI of the cervical spinal cord can reliably discriminate sensory (dorsal) and motor (lateral) columns. From data derived from nine healthy volunteers, two raters quantified column‐specific parallel (λ||) and perpendicular (λ⟂) diffusivity, fractional anisotropy (FA), mean diffusivity (MD), and MT‐weighted signal intensity relative to cerebrospinal fluid (MTCSF) over two time‐points separated by more than 1 week. Cross‐sectional means and standard deviations of these measures in the lateral and dorsal columns were as follows: λ||: 2.13 ± 0.14 and 2.14 ± 0.11 μm2/ms; λ⟂: 0.67 ± 0.16 and 0.61 ± 0.09 μm2/ms; MD: 1.15 ± 0.15 and 1.12 ± 0.08 μm2/ms; FA: 0.68 ± 0.06 and 0.68 ± 0.05; MTCSF: 0.52 ± 0.05 and 0.50 ± 0.05. We examined the variability and interrater and test‐retest reliability for each metric. These column‐specific MR measurements are expected to enhance understanding of the intimate structure‐function relationship in the cervical spinal cord and may be useful for the assessment of disease progression. Copyright


Proceedings of the National Academy of Sciences of the United States of America | 2001

Specific repression of β-globin promoter activity by nuclear ferritin

Robert H. Broyles; Visar Belegu; Christina R. DeWitt; Sandeep N. Shah; Charles A. Stewart; Quentin N. Pye; Robert A. Floyd

Developmental hemoglobin switching involves sequential globin gene activations and repressions that are incompletely understood. Earlier observations, described herein, led us to hypothesize that nuclear ferritin is a repressor of the adult β-globin gene in embryonic erythroid cells. Our data show that a ferritin-family protein in K562 cell nuclear extracts binds specifically to a highly conserved CAGTGC motif in the β-globin promoter at −153 to −148 bp from the cap site, and mutation of the CAGTGC motif reduces binding 20-fold in competition gel-shift assays. Purified human ferritin that is enriched in ferritin-H chains also binds the CAGTGC promoter segment. Expression clones of ferritin-H markedly repress β-globin promoter-driven reporter gene expression in cotransfected CV-1 cells in which the β-promoter has been stimulated with the transcription activator erythroid Krüppel-like factor (EKLF). We have constructed chloramphenicol acetyltransferase reporter plasmids containing either a wild-type or mutant β-globin promoter for the −150 CAGTGC motif and have compared the constructs for susceptibility to repression by ferritin-H in cotransfection assays. We find that stimulation by cotransfected EKLF is retained with the mutant promoter, whereas repression by ferritin-H is lost. Thus, mutation of the −150 CAGTGC motif not only markedly reduces in vitro binding of nuclear ferritin but also abrogates the ability of expressed ferritin-H to repress this promoter in our cell transfection assay, providing a strong link between DNA binding and function, and strong support for our proposal that nuclear ferritin-H is a repressor of the human β-globin gene. Such a repressor could be helpful in treating sickle cell and other genetic diseases.


PLOS ONE | 2015

Reproducibility and Temporal Structure in Weekly Resting-State fMRI over a Period of 3.5 Years

Ann S. Choe; Craig K. Jones; Suresh Joel; John Muschelli; Visar Belegu; Brian Caffo; Martin A. Lindquist; Peter C.M. van Zijl; James J. Pekar

Resting-state functional MRI (rs-fMRI) permits study of the brain’s functional networks without requiring participants to perform tasks. Robust changes in such resting state networks (RSNs) have been observed in neurologic disorders, and rs-fMRI outcome measures are candidate biomarkers for monitoring clinical trials, including trials of extended therapeutic interventions for rehabilitation of patients with chronic conditions. In this study, we aim to present a unique longitudinal dataset reporting on a healthy adult subject scanned weekly over 3.5 years and identify rs-fMRI outcome measures appropriate for clinical trials. Accordingly, we assessed the reproducibility, and characterized the temporal structure of, rs-fMRI outcome measures derived using independent component analysis (ICA). Data was compared to a 21-person dataset acquired on the same scanner in order to confirm that the values of the single-subject RSN measures were within the expected range as assessed from the multi-participant dataset. Fourteen RSNs were identified, and the inter-session reproducibility of outcome measures—network spatial map, temporal signal fluctuation magnitude, and between-network connectivity (BNC)–was high, with executive RSNs showing the highest reproducibility. Analysis of the weekly outcome measures also showed that many rs-fMRI outcome measures had a significant linear trend, annual periodicity, and persistence. Such temporal structure was most prominent in spatial map similarity, and least prominent in BNC. High reproducibility supports the candidacy of rs-fMRI outcome measures as biomarkers, but the presence of significant temporal structure needs to be taken into account when such outcome measures are considered as biomarkers for rehabilitation-style therapeutic interventions in chronic conditions.


Frontiers in Human Neuroscience | 2013

Extensive neurological recovery from a complete spinal cord injury: a case report and hypothesis on the role of cortical plasticity

Ann S. Choe; Visar Belegu; Shoko Yoshida; Suresh Joel; Cristina L. Sadowsky; Seth A. Smith; Peter C.M. van Zijl; James J. Pekar; John W. McDonald

Neurological recovery in patients with severe spinal cord injury (SCI) is extremely rare. We have identified a patient with chronic cervical traumatic SCI, who suffered a complete loss of motor and sensory function below the injury for 6 weeks after the injury, but experienced a progressive neurological recovery that continued for 17 years. The extent of the patients recovery from the severe trauma-induced paralysis is rare and remarkable. A detailed study of this patient using diffusion tensor imaging (DTI), magnetization transfer imaging (MTI), and resting state fMRI (rs-fMRI) revealed structural and functional changes in the central nervous system that may be associated with the neurological recovery. Sixty-two percent cervical cord white matter atrophy was observed. DTI-derived quantities, more sensitive to axons, demonstrated focal changes, while MTI-derived quantity, more sensitive to myelin, showed a diffuse change. No significant cortical structural changes were observed, while rs-fMRI revealed increased brain functional connectivity between sensorimotor and visual networks. The study provides comprehensive description of the structural and functional changes in the patient using advanced MR imaging technique. This multimodal MR imaging study also shows the potential of rs-fMRI to measure the extent of cortical plasticity.


Scientific Reports | 2016

Mechanisms of PDGF siRNA-mediated inhibition of bone cancer pain in the spinal cord

Yang Xu; Jia Liu; Mu He; Ran Liu; Visar Belegu; Ping Dai; Wei Liu; Wei Wang; Qing Jie Xia; Fei Fei Shang; Chao Zhi Luo; Xue Zhou; Su Liu; Johnw McDonald; Jin Liu; Yun Xia Zuo; Fei Liu; Ting Hua Wang

Patients with tumors that metastasize to bone frequently suffer from debilitating pain, and effective therapies for treating bone cancer are lacking. This study employed a novel strategy in which herpes simplex virus (HSV) carrying a small interfering RNA (siRNA) targeting platelet-derived growth factor (PDGF) was used to alleviate bone cancer pain. HSV carrying PDGF siRNA was established and intrathecally injected into the cavum subarachnoidale of animals suffering from bone cancer pain and animals in the negative group. Sensory function was assessed by measuring thermal and mechanical hyperalgesia. The mechanism by which PDGF regulates pain was also investigated by comparing the differential expression of pPDGFRα/β and phosphorylated ERK and AKT. Thermal and mechanical hyperalgesia developed in the rats with bone cancer pain, and these effects were accompanied by bone destruction in the tibia. Intrathecal injection of PDGF siRNA and morphine reversed thermal and mechanical hyperalgesia in rats with bone cancer pain. In addition, we observed attenuated astrocyte hypertrophy, down-regulated pPDGFRα/β levels, reduced levels of the neurochemical SP, a reduction in CGRP fibers and changes in pERK/ERK and pAKT/AKT ratios. These results demonstrate that PDGF siRNA can effectively treat pain induced by bone cancer by blocking the AKT-ERK signaling pathway.


Stem Cell Research | 2018

Spinal cord organogenesis model reveals role of Flk1+ cells in self-organization of neural progenitor cells into complex spinal cord tissue

Baohan Pan; Hushan Ao; Su Liu; Yuming Xu; John W. McDonald; Visar Belegu

A platform for studying spinal cord organogenesis in vivo where embryonic stem cell (ESC)-derived neural progenitor cells (NPC) self-organize into spinal cord-like tissue after transplantation in subarachnoid space of the spinal cord has been described. We advance the applicability of this platform by imaging in vivo the formed graft through T2w magnetic resonance imaging (MRI). Furthermore, we used diffusion tensor imaging (DTI) to verify the stereotypical organization of the graft showing that it mimics the host spinal cord. Within the graft white matter (WM) we identified astrocytes that form glial limitans, myelinating oligodendrocytes, and myelinated axons with paranodes. Within the graft grey matter (GM) we identified cholinergic, glutamatergic, serotonergic and dopaminergic neurons. Furthermore, we demonstrate the presence of ESC-derived complex vasculature that includes the presence of blood brain barrier. In addition to the formation of mature spinal cord tissue, we describe factors that drive this process. Specifically, we identify Flk1+ cells as necessary for spinal cord formation, and synaptic connectivity with the host spinal cord and formation of host-graft chimeric vasculature as contributing factors. This model can be used to study spinal cord organogenesis, and as an in vivo drug discovery platform for screening potential therapeutic compounds and their toxicity.


Journal of Stem Cell Research & Therapy | 2015

Myelination of Motor Neurons Derived from Mouse Embryonic StemCells by Oligodendrocytes Derived from Mouse Embryonic Stem Cells in aMicrofluidic Compartmentalized Platform

Su Liu; Ping Xiang; Aysel Cetinkaya Fisgin; Visar Belegu; Nitish V. Thakor; John W. McDonald; In Hong Yang

Neuronal cell death and demyelination are devastating aspects of neurological diseases, such as multiple sclerosis, and spinal cord injury. Stem cell derived neurons and oligodendrocytes have shown potential as therapeutics for replacement of damaged neurons and remyelination of demyelinated axons in the central nervous system (CNS). However, in some cases, the neurons and axons are damaged so severely that they should be replaced. In this paper, we examined the hypothesis that stem cell derived oligodendrocytes can myelinate axons of stem cell derived motor neurons in a microfluidic platform, which mimics the isolated in vivo environment. The polydimethylsiloxane (PDMS) microfluidic platform achieves compartmentalization of mouse embryonic stem cells (mESCs) derived motor neurons and mESCs derived oligodendrocytes, while allowing the axons of the motor neurons to pass through microchannels and reach the oligodendrocytes. As results show, axons of mESCs derived motor neurons were subjected to myelination by mESCs derived oligodendrocytes shown by myelin basic protein immunostaining and electron microscopy. These functioning neuron and oligodendrocyte units may be a very useful tool to study stem cell replacement therapies for nerve injuries where nerve reconstruction would be beneficial.


Developmental Biology | 2010

A developmental switch yields a treatment for beta thalassemias and sickle cell disease

Robert H. Broyles; Visar Belegu; Austin C. Roth; Robert A. Floyd; Emily Curry; Marie Trudel

Program/Abstract # 394 Mechanical forces from the fetal breathing-like movements are transduced via Satb1 and Myb during mouse and human lung organogenesis Boris Kablar, Dijana Gugic, Asja Miletic, Mirna Saraga-Babic Dept. of Anat. and Neurobiol., Dalhousie Univ., Halifax, NS, Canada Present address: Dept. of Biol., Frostburg State Univ., MD, USA Dept. of Hist. and Embryol., Univ. of Split, Croatia Dept. of Pathol., Forensic Med. and Cytology, Univ. of Split, Croatia


Journal of Neurotrauma | 2006

Demyelination and remyelination after spinal cord injury.

John W. McDonald; Visar Belegu

Collaboration


Dive into the Visar Belegu's collaboration.

Top Co-Authors

Avatar

John W. McDonald

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Robert A. Floyd

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Robert H. Broyles

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Austin C. Roth

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

Peter C.M. van Zijl

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Marie Trudel

Université de Montréal

View shared research outputs
Top Co-Authors

Avatar

Ann S. Choe

Kennedy Krieger Institute

View shared research outputs
Top Co-Authors

Avatar

Charles A. Stewart

Oklahoma Medical Research Foundation

View shared research outputs
Top Co-Authors

Avatar

James J. Pekar

Kennedy Krieger Institute

View shared research outputs
Top Co-Authors

Avatar

Quentin N. Pye

Oklahoma Medical Research Foundation

View shared research outputs
Researchain Logo
Decentralizing Knowledge